Current Management Challenges in Chronic Obstructive Pulmonary Disease (COPD)
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 35424
Special Issue Editor
Special Issue Information
Dear Colleagues,
Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory disease mainly related to smoking exposure, for which the management guidelines have evolved over the last two decades based on the evidence coming from various clinical trials and answering various research questions. It is currently known that lung function impairment alone can no longer be considered as an appropriate marker of disease severity, and that there are various phenotypes of the disease which require an appropriate tailoring of the available therapeutic options, that the use of inhaled corticosteroids is increasingly restricted unlike asthma, and that disease morbidity (exacerbations number and severity) is one of the features used to guide the intensiveness of the management approach in individual patients.
However, despite this evidence, many therapeutic challenges still exist in COPD: end-stage disease can benefit from palliative care, but it is not known how early this should be; vaccination in elderly patients with COPD is still unclear in terms of effectiveness and the types of approaches; it is not known when and why inhaled corticosteroids doses should be reduced; and the appropriateness and effects of home-based rehabilitation programs are not also clear. Furthermore, in the ongoing COVID-19 era which is taking a heavy toll on all of us and indeed on COPD patients, the management of such patients is challenging and should be adjusted accordingly. All these challenges are addressed hopefully to the benefit of the healthcare community and of COPD patients by this issue of Medicina.
Dr. Sabina Antonela Antoniu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic obstructive pulmonary disease
- elderly
- palliative care
- health status
- pulmonary rehabilitation
- inhaled corticosteroids
- exacerbations
- immunization
- vaccine
- COVID-19
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.